EP3432872
EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA
:
EP einkaleyfi: Þýðing ekki lögð inn:
16.3.2017:
25.8.2021:
17770846.8
:
15.3.2037
:
EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA
16.3.2017
25.8.2021
:
Orbus Therapeutics, Inc.:
2475 East Bayshore Road Suite 105, Palo Alto, CA 94303, US
:
LEVIN, Victor, A.:
Palo Alto, CA 94303, US
:
201662312623 P:
24.3.2016:
US
:
US2017022718:
16.3.2017
:
A61K 31/195, A61K 31/197, A61P 35/04